Advertisement
Clinical study| Volume 57, P116-120, November 2018

Deficit in specific cognitive domains associated with dementia in Parkinson’s disease

Published:August 24, 2018DOI:https://doi.org/10.1016/j.jocn.2018.08.016

      Highlights

      • Domain specific cognitive disturbances are present in Parkinson’s disease (PD).
      • Intact executive, attention and memory domains characterise PD without dementia.
      • Deficits in several cognitive domains characterise dementia in PD.

      Abstract

      Impairment in different cognitive domains such as executive functions, language, memory and visuospatial skills occur frequently in Parkinson disease (PD) leading to significant disability and deterioration in quality of life. Heterogeneity of cognitive impairment enhances risk of developing dementia as disease progress. The objective is to explore the pattern of cognitive impairment with reference to the affected domains in PD with or without dementia relative to healthy controls. In this study, 110 PD patients and 26 healthy control were categorized into groups using Mini Mental State Examination and Clinical Dementia Rating scores as PD without dementia (PDND, n = 65; MMSE score >24; CDR = 0–1), PD with dementia (PDD, n = 45; MMSE score ≤24; CDR = 0.5–3) and healthy control (HC, n = 26; MMSE score >26; CDR = 0). Both Patients and controls underwent individual assessments of working memory, semantic memory, attention, language, executive functions, psychomotor and visuospatial skills and dementia using different cognitive function tests. Findings revealed lower scores of word memory, attention, psychomotor speed, visuospatial skills and executive functions in PDD compared to PDND. Interestingly, in PDD scores of picture memory, semantic memory and language functions were comparable with PDND. Compared to HC, PDND had no impairment in working memory, attention and executive functions, whereas PDD had lower scores in all the cognitive domains tested. Results indicate that the deficits in word memory, attention, psychomotor speed, visuospatial skills and executive functions distinguishes PDD from PDND. Impairment in specific cognitive domains may be a biomarker for predicting onset of dementia in Parkinson’s disease.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Neuroscience
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aarsland D.
        • Bronnick K.
        • Williams-Gray C.
        • Weintraub D.
        • Marder K.
        • Kulisevsky J.
        • et al.
        Mild cognitive impairment in Parkinson disease A multicenter pooled analysis.
        Neurology. 2010; 75: 1062-1069
        • Goldman J.
        • Litvan I.
        Mild Cognitive Impairment in Parkinson’s Disease.
        Minerva Med. 2011; 102: 441-459
        • Hely M.A.
        • Reid W.G.J.
        • Adena M.A.
        • Halliday G.M.
        • Morris J.G.L.
        The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years.
        Mov Disord Off J Mov Disord Soc. 2008; 23: 837-844https://doi.org/10.1002/mds.21956
        • Hughes T.A.
        • Ross H.F.
        • Musa S.
        • Bhattacherjee S.
        • Nathan R.N.
        • Mindham R.H.S.
        • et al.
        A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease.
        Neurology. 2000; 54: 1596-1603https://doi.org/10.1212/WNL.54.8.1596
        • Llibre Rodriguez J.J.
        • Ferri C.P.
        • Acosta D.
        • Guerra M.
        • Huang Y.
        • Jacob K.S.
        • et al.
        Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey.
        Lancet Lond Engl. 2008; 372: 464-474https://doi.org/10.1016/S0140-6736(08)61002-8
        • Kehagia A.A.
        • Barker R.A.
        • Robbins T.W.
        Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease.
        Lancet Neurol. 2010; 9: 1200-1213https://doi.org/10.1016/S1474-4422(10)70212-X
        • Brown R.G.
        • Marsden C.D.
        Cognitive function in Parkinson’s disease: From description to theory.
        Trends Neurosci. 1990; 13: 21-29https://doi.org/10.1016/0166-2236(90)90058-I
        • Levin B.E.
        • Katzen H.L.
        Early cognitive changes and nondementing behavioral abnormalities in Parkinson’s disease.
        Adv Neurol. 2005; 96: 84-94
        • Bronnick K.
        • Ehrt U.
        • Emre M.
        • De Deyn P.P.
        • Wesnes K.
        • Tekin S.
        • et al.
        Attentional deficits affect activities of daily living in dementia-associated with Parkinson’s disease.
        J Neurol Neurosurg Psychiatry. 2006; 77: 1136-1142https://doi.org/10.1136/jnnp.2006.093146
        • Beatty W.W.
        • Ryder K.A.
        • Gontkovsky S.T.
        • Scott J.G.
        • McSwan K.L.
        • Bharucha K.J.
        Analyzing the subcortical dementia syndrome of Parkinson’s disease using the RBANS.
        Arch Clin Neuropsychol Off J Natl Acad Neuropsychol. 2003; 18: 509-520
        • Chiaravalloti N.D.
        • Ibarretxe-Bilbao N.
        • DeLuca J.
        • Rusu O.
        • Pena J.
        • García-Gorostiaga I.
        • et al.
        The source of the memory impairment in Parkinson’s disease: acquisition versus retrieval.
        Mov Disord Off J Mov Disord Soc. 2014; 29: 765-771https://doi.org/10.1002/mds.25842
        • Hughes A.J.
        • Daniel S.E.
        • Kilford L.
        • Lees A.J.
        Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases.
        J Neurol Neurosurg Psychiatry. 1992; 55: 181-184
        • Hoehn M.M.
        • Yahr M.D.
        Parkinsonism onset, progression, and mortality.
        Neurology. 1967; 17 (427–427)
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. 1975; 12: 189-198
        • Foltynie T.
        • Brayne C.E.G.
        • Robbins T.W.
        • Barker R.A.
        The cognitive ability of an incident cohort of Parkinson’s patients in the UK.
        The CamPaIGN study. Brain. 2004; 127: 550-560https://doi.org/10.1093/brain/awh067
        • Morris J.C.
        The Clinical Dementia Rating (CDR): current version and scoring rules.
        Neurology. 1993; 43: 2412-2414
        • van der Hiele K.
        • Vein A.A.
        • Kramer C.G.S.
        • Reijntjes R.H.A.M.
        • van Buchem M.A.
        • Westendorp R.G.J.
        • et al.
        Memory activation enhances EEG abnormality in mild cognitive impairment.
        Neurobiol Aging. 2007; 28: 85-90https://doi.org/10.1016/j.neurobiolaging.2005.11.006
      1. Classics in the History of Psychology – Stroop (1935) 2017. http://psychclassics.yorku.ca/Stroop/ (accessed July 17, 2017).

        • Pershad D.
        The construction & standardization of a clinical test of memory in simple hindi.
        National Psych Corp. 1977;
        • Pershad D.
        • Verma S.K.
        Handbook Of P G I Battery Of Brain Dysfunction (pgi-Bbd).
        National Psych Corpor. 1990;
        • Reitan R.M.
        Trail making test results for normal and brain-damaged children.
        Percept Mot Skills. 1971; 33: 575-581https://doi.org/10.2466/pms.1971.33.2.575
        • Reitan R.M.
        Validity of the trail making test as an indicator of organic brain damage.
        Percept Mot Skills. 1958; 8: 271-276https://doi.org/10.2466/pms.1958.8.3.271
      2. Mukundan C.R. NIMHANS neuropsychological battery: test descriptions, instructions, clinical data and interpretation. In: Proceedings of the National Workshop in Clinical Neuropsychology; 24–29 October NIMHANS, Bangalore, India. Bangalore; 1996.

        • Aarsland D.
        • Andersen K.
        • Larsen J.P.
        • Lolk A.
        Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study.
        Arch Neurol. 2003; 60: 387-392https://doi.org/10.1001/archneur.60.3.387
        • Cooper J.A.
        • Sagar H.J.
        • Sullivan E.V.
        Short-term memory and temporal ordering in early Parkinson’s disease: effects of disease chronicity and medication.
        Neuropsychologia. 1993; 31: 933-949
        • Hochstadt J.
        • Nakano H.
        • Lieberman P.
        • Friedman J.
        The roles of sequencing and verbal working memory in sentence comprehension deficits in Parkinson’s disease.
        Brain Lang. 2006; 97: 243-257https://doi.org/10.1016/j.bandl.2005.10.011
        • Hanley J.R.
        • Dewick H.C.
        • Davies A.D.
        • Playfer J.
        • Turnbull C.
        Verbal fluency in Parkinson’s disease.
        Neuropsychologia. 1990; 28: 737-741
        • Jellinger K.A.
        Post mortem studies in Parkinson’s disease–is it possible to detect brain areas for specific symptoms?.
        J Neural Transm Suppl. 1999; 56: 1-29
        • Pagonabarraga J.
        • Corcuera-Solano I.
        • Vives-Gilabert Y.
        • Llebaria G.
        • García-Sánchez C.
        • Pascual-Sedano B.
        • et al.
        Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson’s disease.
        PLoS One. 2013; 8e54980https://doi.org/10.1371/journal.pone.0054980
        • Woods S.P.
        • Tröster A.I.
        Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson’s disease.
        J Int Neuropsychol Soc JINS. 2003; 9: 17-24
        • Kourtidou P.
        • Kasselimis D.
        • Potagas C.
        • Zalonis I.
        • Evdokimidis I.
        Effects of mental flexibility and motor dysfunction on cognitive performance in patients with Parkinson’s disease.
        Arch Neurosci. 2015;2.; https://doi.org/10.5812/archneurosci.21087
        • Harnois C.
        • Di Paolo T.
        Decreased dopamine in the retinas of patients with Parkinson’s disease.
        Invest Ophthalmol Vis Sci. 1990; 31: 2473-2475
        • Acevedo A.
        • Loewenstein D.A.
        • Agrón J.
        • Duara R.
        Influence of sociodemographic variables on neuropsychological test performance in Spanish-speaking older adults.
        J Clin Exp Neuropsychol. 2007; 29: 530-544https://doi.org/10.1080/13803390600814740
        • Ganguli M.
        • Ratcliff G.
        • Huff F.J.
        • Belle S.
        • Kancel M.J.
        • Fischer L.
        • et al.
        Effects of age, gender, and education on cognitive tests in a rural elderly community sample: norms from the Monongahela Valley Independent Elders Survey.
        Neuroepidemiology. 1991; 10: 42-52
        • Manly J.J.
        • Jacobs D.M.
        • Sano M.
        • Bell K.
        • Merchant C.A.
        • Small S.A.
        • et al.
        Effect of literacy on neuropsychological test performance in nondemented, education-matched elders.
        J Int Neuropsychol Soc JINS. 1999; 5: 191-202